Skip to content

Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos

Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06926608
Enrollment
408
Registered
2025-04-13
Start date
2025-06-17
Completion date
2029-05-31
Last updated
2026-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Inactivity, Smoking, Smoking Cessation

Brief summary

The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy \[i.e., nicotine replacement therapies (NRT)\], and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

Detailed description

We will conduct a two-arm randomized controlled trial among Latinos who smoke and do not meet the recommended levels of physical activity (N=408). Participants will be recruited via community-based efforts and randomly assigned in a 1:1 ratio to Actívatexto (a mobile intervention that promotes both smoking cessation and physical activity) or Decídetexto (a mobile intervention that solely promotes smoking cessation). All participants will be provided with nicotine replacement therapies and a Fitbit Versa 4 device. Participants in both groups will complete a baseline assessment at enrollment and follow-up assessments at Months 3 and 6.

Interventions

BEHAVIORALActívatexto

Actívatexto is a mobile intervention that promotes both smoking cessation and physical activity. Actívatexto integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

BEHAVIORALDecídetexto

Decídetexto is a mobile intervention that solely promotes smoking cessation. Decídetexto integrates three components: 1) a text messaging program that solely promotes smoking cessation, 2) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 3) an online dashboard where the research team manages participants' incoming and outgoing data from the text messaging program.

Sponsors

University of Rochester
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
Hackensack Meridian Health
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Self-identify as Hispanic and/or Latino * Know how to read and speak English and/or Spanish * Be ≥ 18 years of age * Not meet the recommended levels of physical activity (150 minutes of moderate to vigorous physical activity) * Smoke cigarettes at least 3 days per week * Be interested in quitting smoking in the next 30 days * Have a cellphone with text messaging capability * Know how to utilize text messages * Be willing to wear a wearable device daily to monitor physical activity * Be willing to complete all study visits

Exclusion criteria

* Use of tobacco products other than cigarettes in the past 30 days (including e-cigarettes) * Being pregnant or breastfeeding * Plan to move from their current residence in the next six months * Another household member enrolled in the study * Unable to become more physically active or engage in a fitness appraisal

Design outcomes

Primary

MeasureTime frameDescription
Percent of participants with cotinine verified 7-day point prevalence abstinenceMonth 6Cotinine levels ≤15 ng/mL in saliva

Secondary

MeasureTime frameDescription
Percent of participants with self-reported 7-day point prevalence abstinenceMonth 6No cigarettes, "not even a puff", in the past 7 days

Countries

United States

Contacts

CONTACTFrancisco Cartujano, MD
francisco_cartujano@urmc.rochester.edu(585) 273-1646

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 19, 2026